On the other hand, if GDNF release is a protective reaction to degeneration, its level may increase proportionally to the atrophy severity regardless of PSP clinical phenotype; due to the undefined and possibly multifactorial pathomechanism of this disease, presumptions such as this are limited. The gene discussed is GDNF; the disease is supranuclear palsy, progressive, 1.